{"transactions":[{"id":1568,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-03T01:48:34.000Z","date":"2026-08-25","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted shares of the Issuer's common stock, par value $0.01 which vested fully on the date of grant."}],"balance_after":265231,"source":{"system":"sec-edgar","filing":"0001104659-26-104862","document":"tm2624717-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465926104862/tm2624717-5_4seq1.xml","form_type":"4"}},{"id":707188,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T21:00:02.000Z","date":"2026-03-31","kind":"other","planned":false,"acquired":true,"shares":0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"date","element":"transactionDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The reported grant was made in error and has been cancelled."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported grant was made in error and has been cancelled."}],"balance_after":0,"derivative":{"underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001683168-26-005619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826005619/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-02"}},{"id":771566,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T22:43:41.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the holder's options shall vest and become immediately exercisable upon the holder's completion of one year of service following May 18, 2026."}],"balance_after":30000,"derivative":{"exercise_price":4.8,"expiration_date":"2036-05-18","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-063990","document":"tm2615135-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465926063990/tm2615135-2_4seq1.xml","form_type":"4"}},{"id":820571,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:17:39.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":119170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein."}],"balance_after":119170,"derivative":{"exercise_price":0.67,"expiration_date":"2036-03-30","underlying":"Common Stock","underlying_shares":119170},"source":{"system":"sec-edgar","filing":"0001683168-26-002633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316826002633/ownership.xml","form_type":"4"}},{"id":873884,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T00:45:36.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 100,000 restricted stock units (\"RSUs\"), which such RSUs shall vest on the thirtieth (30th) day following the date of grant, provided that the reporting person remains employed by or is providing services to the Issuer. The RSUs were granted subject to the closing of the transaction contemplated by that certain securities purchase agreement, dated as of February 24, 2026, by and between the Company and the purchaser signatory thereto, which occurred on February 27, 2026."}],"balance_after":215231,"source":{"system":"sec-edgar","filing":"0001104659-26-022417","document":"tm267701-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465926022417/tm267701-5_4seq1.xml","form_type":"4"}},{"id":971653,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-12T22:08:04.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":63233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein."}],"balance_after":63233,"derivative":{"exercise_price":1.22,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":63233},"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":971652,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:08:04.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":33750,"price":1.02,"value":34425.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":41250,"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":971651,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T22:08:04.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001683168-25-009116","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316825009116/ownership.xml","form_type":"4"}},{"id":1016396,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-17T21:14:09.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by a committee of the Issuer's board of directors on July 14, 2025 subject to shareholder approval of an amendment to the Company's 2020 Equity Incentive Plan (the \"Plan\") to increase the number of shares authorized for issuance of awards under the Plan. The Company received shareholder approval of the amendment to the Plan on August 6, 2025."}],"balance_after":7000,"derivative":{"exercise_price":10.38,"exercise_date":"2026-07-14","expiration_date":"2035-07-14","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001104659-25-100464","document":"tm2529010-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465925100464/tm2529010-6_4seq1.xml","form_type":"4"}},{"id":1016395,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-17T21:14:09.000Z","date":"2025-10-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4000,"price":7.23,"value":28920.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":16574,"source":{"system":"sec-edgar","filing":"0001104659-25-100464","document":"tm2529010-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465925100464/tm2529010-6_4seq1.xml","form_type":"4"}},{"id":1016394,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-17T21:14:09.000Z","date":"2025-10-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 10,000 restricted stock units granted on October 17, 2025, under TAO Synergies Inc.'s (the \"Issuer\") 2020 Equity Incentive Plan which vested immediately and (ii) 10,574 shares of common stock."}],"balance_after":20574,"source":{"system":"sec-edgar","filing":"0001104659-25-100464","document":"tm2529010-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465925100464/tm2529010-6_4seq1.xml","form_type":"4"}},{"id":1094591,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:06:45.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":6164,"price":7.85,"value":48387.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction."}],"balance_after":10574,"source":{"system":"sec-edgar","filing":"0001104659-25-065282","document":"tm2519649-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465925065282/tm2519649-5_4seq1.xml","form_type":"4"}},{"id":1094590,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-07-02T20:06:45.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":15410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 15,410 restricted stock units granted on June 30, 2025, under the Issuer's 2020 Equity Incentive Plan which vested immediately upon issuance and (ii) 1,328 shares of common stock."}],"balance_after":16738,"source":{"system":"sec-edgar","filing":"0001104659-25-065282","document":"tm2519649-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465925065282/tm2519649-5_4seq1.xml","form_type":"4"}},{"id":1124656,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2025-06-03T12:01:35.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":117886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents stock options to purchase up to 117,886 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents stock options to purchase up to 117,886 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date."}],"balance_after":117886,"derivative":{"exercise_price":0.968,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":117886},"source":{"system":"sec-edgar","filing":"0001104659-25-055729","document":"tm2517003-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465925055729/tm2517003-2_4seq1.xml","form_type":"4"}},{"id":1124655,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2025-06-03T12:01:35.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":107407,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person received fully vested restricted stock units, in consideration of the reporting person's Board fees decrease effective in the fourth quarter of 2024."}],"balance_after":115231,"source":{"system":"sec-edgar","filing":"0001104659-25-055729","document":"tm2517003-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465925055729/tm2517003-2_4seq1.xml","form_type":"4"}},{"id":1361626,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-11-18T23:37:03.000Z","date":"2024-11-15","kind":"grant","planned":false,"acquired":true,"shares":30825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents stock options to purchase up to 30,825 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents stock options to purchase up to 30,825 shares of Common Stock with such stock options vesting 100% on the first anniversary of the date of the grant, provided that the reporting person is providing services to the Company through such vesting date."}],"balance_after":30825,"derivative":{"exercise_price":1.6548,"expiration_date":"2034-11-15","underlying":"Common Stock","underlying_shares":30825},"source":{"system":"sec-edgar","filing":"0001104659-24-120237","document":"tm2428798-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465924120237/tm2428798-4_4seq1.xml","form_type":"4"}},{"id":1452870,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:59:12.000Z","date":"2024-04-30","kind":"grant","planned":false,"acquired":true,"shares":38009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein."}],"balance_after":38009,"derivative":{"exercise_price":2.12,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":38009},"source":{"system":"sec-edgar","filing":"0001683168-24-004918","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316824004918/ownership.xml","form_type":"4"}},{"id":1731601,"issuer":{"id":8256,"kind":"organization","name":"PharmaCyte Biotech, Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-22T22:02:21.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":61248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61248,"derivative":{"exercise_price":2.18,"exercise_date":"2023-11-20","expiration_date":"2033-11-20","underlying":"Common Stock","underlying_shares":61248},"source":{"system":"sec-edgar","filing":"0001683168-23-008434","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157075/000168316823008434/ownership.xml","form_type":"4"}},{"id":1873242,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T12:32:51.000Z","date":"2023-05-30","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.247,"value":6175.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2466 to $0.2480, inclusive. The reporting person undertakes to provide to XWELL, Inc., any security holder of XWELL, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":156485,"source":{"system":"sec-edgar","filing":"0001062993-23-012491","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000106299323012491/form4.xml","form_type":"4"}},{"id":1874604,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T12:34:03.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":0.25,"value":6250.0,"ownership":{"direct":true},"balance_after":131485,"source":{"system":"sec-edgar","filing":"0001062993-23-012403","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000106299323012403/form4.xml","form_type":"4"}},{"id":2058680,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-10T02:37:07.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This grant is pursuant to the directors compensation plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each calendar quarter, such that the options will be fully vested as of December 31, 2023."}],"balance_after":300000,"derivative":{"exercise_price":0.4,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001235110-23-000004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000123511023000004/edgar.xml","form_type":"4/A","original_submission_date":"2023-01-09"}},{"id":2058675,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-09T20:00:57.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2023."}],"balance_after":300000,"derivative":{"exercise_price":0.3293,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950138-23-000008","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013823000008/edgar.xml","form_type":"4"}},{"id":2079540,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-12-21T01:02:21.000Z","date":"2022-12-16","kind":"sale","acquired":false,"shares":27000,"price":1.1719,"value":31641.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":33198,"source":{"system":"sec-edgar","filing":"0001104659-22-128771","document":"tm2233089-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465922128771/tm2233089-6_4seq1.xml","form_type":"4"}},{"id":2099822,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-02T00:54:41.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This filing amends the Form 4, filed on November 17, 2022 by Mr. Weinstein to reflect the lower number of options allowed to be granted pursuant to the per-participant grant limit contained in the Issuer's 2020 Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":75000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-22-123808","document":"tm2231816-8_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465922123808/tm2231816-8_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-11-17"}},{"id":2111817,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-17T21:02:48.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vested 50% on November 15, 2022 (the \"Issuance Date\") and shall vest 50% on the six-month anniversary of the Issuance Date. The options shall be exercisable for a period of ten years from the date of the grant, irrespective of whether or not the reporting person continues to provide services to the Issuer."}],"balance_after":96000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-11-15","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0001104659-22-119880","document":"tm2230820-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465922119880/tm2230820-5_4seq1.xml","form_type":"4"}},{"id":2291806,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-22T23:59:49.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":45000,"price":1.06,"value":47700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the correction of an error in Column 5 reported in the Reporting Person's Form 4 filed on January 31, 2022."}],"balance_after":106485,"source":{"system":"sec-edgar","filing":"0000950138-22-000108","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013822000108/edgar.xml","form_type":"4"}},{"id":2421046,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-01T01:19:24.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":46875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022."}],"balance_after":46875,"derivative":{"exercise_price":1.28,"expiration_date":"2032-01-26","underlying":"Common Stock","underlying_shares":46875},"source":{"system":"sec-edgar","filing":"0000950138-22-000034","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013822000034/edgar.xml","form_type":"4"}},{"id":2421045,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-01T01:19:24.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022."}],"balance_after":196485,"source":{"system":"sec-edgar","filing":"0000950138-22-000034","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013822000034/edgar.xml","form_type":"4"}},{"id":2428668,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-21T22:08:18.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":45000,"price":1.5608,"value":70236.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.58, inclusive. The reporting person undertakes to provide to XpresSpa Group, Inc. any security holder of XpresSpa Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":120235,"source":{"system":"sec-edgar","filing":"0000950138-22-000023","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013822000023/edgar.xml","form_type":"4"}},{"id":2536245,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-22T20:15:19.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":63000,"price":1.4319,"value":90209.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.41 to $1.44, inclusive. The reporting person undertakes to provide to XpresSpa Group, Inc. any security holder of XpresSpa Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":165235,"source":{"system":"sec-edgar","filing":"0000950138-21-000470","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013821000470/edgar.xml","form_type":"4"}},{"id":2621133,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-30T21:22:59.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of June 30, 2022."}],"balance_after":228235,"source":{"system":"sec-edgar","filing":"0000950138-21-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000095013821000394/edgar.xml","form_type":"4"}},{"id":2633053,"issuer":{"id":7482,"kind":"organization","name":"TAO Synergies Inc."},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2021-07-15T22:06:13.000Z","date":"2021-07-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 60,000 restricted stock units granted on July 13, 2021 (the \"Grant Date\") under the Issuer's 2020 Equity Incentive Plan which will vest 50% on the six month anniversary of the Grant Date and the remaining 50% on the one year anniversary of the Grant Date."}],"balance_after":60198,"source":{"system":"sec-edgar","filing":"0001104659-21-092716","document":"tm2122331-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465921092716/tm2122331-4_4seq1.xml","form_type":"4"}},{"id":2915254,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-06T21:35:46.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":43077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021."}],"balance_after":43077,"derivative":{"exercise_price":1.19,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":43077},"source":{"system":"sec-edgar","filing":"0001235110-21-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000123511021000002/edgar.xml","form_type":"4"}},{"id":2915253,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T21:35:46.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":28235,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2021."}],"balance_after":28235,"source":{"system":"sec-edgar","filing":"0001235110-21-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000123511021000002/edgar.xml","form_type":"4"}},{"id":2957972,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":135000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":0.972,"underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957971,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":3.93,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957970,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":18945,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":19.62,"underlying":"Common Stock","underlying_shares":18945},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957969,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":7768,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":10.56,"underlying":"Common Stock","underlying_shares":7768},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957968,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":3125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":25.6,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957967,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrant to Purchase Common Stock","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":1303,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":25,"underlying":"Common Stock","underlying_shares":1303},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957966,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":20313,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, the stock options or warrants, as applicable, were disposed of as follows: the reporting person received an option or warrant, as applicable, to purchase one (1) share of Petros Common Stock for every option or warrant, as applicable, to purchase five (5) shares of Neurotrope common stock held."}],"balance_after":0,"derivative":{"exercise_price":32,"underlying":"Common Stock","underlying_shares":20313},"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2957965,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-12-04T02:40:31.000Z","date":"2020-12-01","kind":"disposition_to_issuer","acquired":false,"shares":3953,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated as of May 17, 2020, by and among Petros Pharmaceuticals, Inc. (\"Petros\"), Neurotrope, Inc. (\"Neurotrope\"), PM Merger Sub 1, LLC, PN Merger Sub 2, Inc. and Metuchen Pharmaceuticals LLC, as amended, (the \"Merger Agreement\") the common stock was disposed of as follows: the reporting person received one (1) share of Petros Common Stock for every five (5) shares of Neurotrope common stock held."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-132150","document":"tm2037705d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920132150/tm2037705d3_4.xml","form_type":"4"}},{"id":2965109,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-27T22:07:47.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will immediately vest and become exercisable subject to and upon consummation of (1) the merger of PM Merger Sub 1, LLC with and into Metuchen Pharmaceuticals, LLC (\"Metuchen\"), with Metuchen surviving as a wholly-owned subsidiary of Petros Pharmaceuticals, Inc. (\"Petros\") and (2) the merger of PN Merger Sub 2, Inc. with and into Neurotrope, Inc. (\"Neurotrope\"), with Neurotrope surviving as a wholly-owned subsidiary of Petros."}],"balance_after":135000,"derivative":{"exercise_price":0.972,"expiration_date":"2030-11-24","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-20-130074","document":"tm2037145d3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000110465920130074/tm2037145d3_4seq1.xml","form_type":"4"}},{"id":3172332,"issuer":{"id":1233,"kind":"organization","name":"XWELL, Inc.","symbol":"XWEL"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-21T23:58:31.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were issued as part of the Issuer's equity grant to directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in equal quarterly installments over a one-year period, with one-fourth vesting on the date of grant and one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2020."}],"balance_after":185000,"derivative":{"exercise_price":0.51,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001104659-20-049352","document":"tm2016454d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410428/000110465920049352/tm2016454d3_4.xml","form_type":"4"}},{"id":3687910,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T23:02:25.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was made pursuant to the terms of the Neurotrope, Inc. 2017 Equity Incentive Plan. The stock options shall vest according to the following schedule: 50% vest on the date of grant, with the remaining stock options vesting in equal quarterly installments over a two-year period following the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":3.93,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-19-002685","document":"tv511525_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420419002685/tv511525_4.xml","form_type":"4"}},{"id":4352463,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2017-04-14T01:45:50.000Z","date":"2017-04-11","kind":"grant","acquired":true,"shares":18945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Such option grant is subject to stockholder approval of the Issuer's 2017 Equity Incentive Plan under which the option was granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a three-year period."}],"balance_after":18945,"derivative":{"exercise_price":19.62,"expiration_date":"2027-04-11","underlying":"Common Stock","underlying_shares":18945},"source":{"system":"sec-edgar","filing":"0001144204-17-020446","document":"v464201_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420417020446/v464201_4.xml","form_type":"4"}},{"id":4515173,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series C Warrant","published_at":"2016-12-20T17:40:11.000Z","date":"2016-12-20","kind":"other","acquired":false,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.01,"exercise_date":"2015-11-13","expiration_date":"2020-11-13","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001144204-16-140449","document":"v455410_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416140449/v455410_4.xml","form_type":"4"}},{"id":4515172,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Warrant","published_at":"2016-12-20T17:40:11.000Z","date":"2016-12-20","kind":"other","acquired":false,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.01,"exercise_date":"2015-11-13","expiration_date":"2020-11-13","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001144204-16-140449","document":"v455410_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416140449/v455410_4.xml","form_type":"4"}},{"id":4515171,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-12-20T17:40:11.000Z","date":"2016-12-20","kind":"other","acquired":true,"shares":41667,"price":0.01,"value":416.67,"ownership":{"direct":true},"balance_after":126438,"source":{"system":"sec-edgar","filing":"0001144204-16-140449","document":"v455410_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416140449/v455410_4.xml","form_type":"4"}},{"id":4515170,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-12-20T17:40:11.000Z","date":"2016-12-20","kind":"other","acquired":true,"shares":41667,"price":0.01,"value":416.67,"ownership":{"direct":true},"balance_after":84771,"source":{"system":"sec-edgar","filing":"0001144204-16-140449","document":"v455410_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416140449/v455410_4.xml","form_type":"4"}},{"id":4542821,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option","published_at":"2016-11-23T22:03:45.000Z","date":"2016-11-21","kind":"grant","acquired":true,"shares":248548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted in connection with the Issuer's grant to certain officers, directors and employees following the final closing of a private placement on November 21, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half of the stock options vest immediately upon grant and the remaining one half vest in equal daily installments over a four-year period beginning on the date of grant."}],"balance_after":248548,"derivative":{"exercise_price":0.33,"expiration_date":"2026-11-21","underlying":"Common Stock","underlying_shares":248548},"source":{"system":"sec-edgar","filing":"0001144204-16-136408","document":"v453764_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416136408/v453764_4.xml","form_type":"4"}},{"id":4546897,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Convertible Preferred Stock","published_at":"2016-11-22T01:55:15.000Z","date":"2016-11-17","kind":"exercise","acquired":false,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Convertible Preferred Stock was convertible into common stock at any time and had no expiration date.  Pursuant to the Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock, as amended, the Series B Convertible Preferred Stock converted automatically on November 17, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock was convertible into common stock at any time and had no expiration date.  Pursuant to the Certificate of Designation, Preferences and Rights of Series B Convertible Preferred Stock, as amended, the Series B Convertible Preferred Stock converted automatically on November 17, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.58,"underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001144204-16-135758","document":"v453579_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416135758/v453579_4.xml","form_type":"4"}},{"id":4546896,"issuer":{"id":144906,"kind":"organization","name":"Neurotrope, Inc.","symbol":"NTRP"},"owners":[{"id":1236,"kind":"person","name":"WEINSTEIN ROBERT","position":1,"cik":"0001213709","reported_name":"WEINSTEIN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2016-11-22T01:55:15.000Z","date":"2016-11-17","kind":"exercise","acquired":true,"shares":43104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person's shares of Series B Convertible Preferred Stock were automatically converted into an aggregate of 43,104 shares of common stock.   This includes 1,437 shares received by the Reporting Person as the result of a reduction in the conversion price from $0.60 per 1/100 of one share of Series B Convertible Preferred Stock to $0.58."}],"balance_after":168105,"source":{"system":"sec-edgar","filing":"0001144204-16-135758","document":"v453579_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1213709/000114420416135758/v453579_4.xml","form_type":"4"}}]}